Chemours Co current report, 30 June 2023

Business Context and Reporting Period

This Form 8-K filing by The Chemours Company (Chemours) is dated June 30, 2023. The report details the entry into a binding settlement agreement regarding per- and polyfluoroalkyl substances (PFAS) drinking water claims. The agreement resolves claims from a defined class of U.S. public water systems involved in the South Carolina aqueous film-forming foam (AFFF) multi-district litigation.

Key Financial Metrics

The filing discloses a specific financial impact related to the settlement but does not provide broader operational metrics such as revenue, profit, or cash flow for the period.

  • Chemours Settlement Contribution: Approximately $592 million (50% of the total fund).
  • Total Settlement Fund: $1.185 billion.
  • Pre-tax Charge: Chemours will record a pre-tax charge of $592 million in the quarter ending June 30, 2023, excluding legal fees.
  • Funding Timeline: Full funding is required within ten business days following preliminary court approval.

Material Changes

The primary material change is the execution of the Settlement Agreement on June 30, 2023, which formalizes a previously disclosed Memorandum of Understanding (MOU). This agreement establishes a definitive liability for Chemours of approximately $592 million to resolve drinking water claims from the settlement class, which covers approximately 88% of the U.S. population served by systems required to test under EPA rules.

Guidance, Outlook, Risks, and Contingencies

Management Commentary: The settlement is described as a compromise and not an admission of liability or fault. The Companies deny the allegations in the underlying litigation and reserve all legal defenses if the settlement is not approved.

Contingencies:

  • The agreement is subject to preliminary and final approval by the United States District Court for the District of South Carolina.
  • The Companies retain the right to terminate the settlement if the level of class member opt-outs exceeds a specified threshold.
  • If the settlement is not approved, the Companies will continue to litigate the claims.

Risks and Exclusions:

  • The settlement does not resolve claims from public water systems excluded from the class (e.g., state/federal-owned systems, small systems without detected PFAS, or those in the lower Cape Fear River Basin of North Carolina unless they opt-in).
  • It does not cover future claims from systems that have not yet detected PFAS contamination.
  • It does not resolve non-drinking water claims, such as stormwater, wastewater, personal injury, or natural resource damages.

Investor Verification Checklist

  • Verify the final court approval status of the Settlement Agreement.
  • Monitor the percentage of class members opting out of the settlement to assess termination risk.
  • Review the impact of the $592 million pre-tax charge on the Q2 2023 earnings report.
  • Assess the scope of remaining litigation risks, specifically regarding personal injury and natural resource damage claims not covered by this agreement.